2010Zhongguo xin yao zazhiRequires access

Pharmacokinetics and bioequivalence of fudosteine granules and tablets in healthy volunteers

Yan Dong

Open publisher page 0 citations

Abstract

Objective: To evaluate the pharmacokinetics and bioequivalence of two preparations of fudosteine.Methods: In a randomized,crossover and self-control study,20 healthy male volunteers were given a single oral dose(400 mg) of test(granules) and reference(tables) prepatations.Serial plasma samples were analyzed by HPLC-MS/MS.Pharmacokinetic parameters were calculated and compared statistically to evaluated bioequivalence between the two preparations using DAS 2.1 program.Results: The major pharmacokinetic parameters of the reference and test preparations were as follows: Cmax(10.89±3.45) and(10.99±3.01) μg·mL-1,Tmax(0.43±0.09) and(0.38±0.14) h,t1/2(3.46±0.72) and(3.19±0.70) h,AUC0~t(23.17±7.47) and(23.17±6.64) μg·h·mL-1,AUC0~∞(25.13±7.63) and(24.97±6.94) μg·h·mL-1.The relative bioavailability of two preparations was(101.5±11.2) %.No significant differeneces between the two preparations were found in Cmax,Tmax and AUC.Conclusion: The test and reference preparations of fudosteine are bioequivalent.

About this research paper

What this paper is about

Objective: To evaluate the pharmacokinetics and bioequivalence of two preparations of fudosteine.Methods: In a randomized,crossover and self-control study,20 healthy male volunteers were given a single oral dose(400 mg) of test(granules) and reference(tables) prepatations.Serial plasma samples were analyzed by HPLC-MS/MS.Pharmacokinetic parameters were calculated and compared statistically to evaluated bioequivalence between the two preparations using DAS 2.1 program.Results: The major pharmacokinetic parameters of the reference and test preparations were as follows: Cmax(10.89±3.45) and(10.99±3.01) μg·mL-1,Tmax(0.43±0.09) and(0.38±0.14) h,t1/2(3.46±0.72) and(3.19±0.70) h,AUC0~t(23.17±7.47) and(23.17±6.64) μg·h·mL-1,AUC0~∞(25.13±7.63) and(24.97±6.94) μg·h·mL-1.The relative bioavailability of two preparations was(101.5±11.2) %.No significant differeneces between the two preparations were found in Cmax,Tmax and AUC.Conclusion: The test and reference preparations of fudosteine are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the pharmacokinetics and bioequivalence of two preparations of fudosteine.Methods: In a randomized,crossover and self-control study,20 healthy male volunteers were given a single oral dose(400 mg) of test(granules) and reference(tables) prepatations.Serial plasma samples were analyzed by HPLC-MS/MS.Pharmacokinetic parameters were calculated and compared statistically to evaluated bioequivalence between the two preparations using DAS 2.1 program.Results: The major pharmacokinetic parameters of the reference and test preparations were as follows: Cmax(10.89±3.45) and(10.99±3.01) μg·mL-1,Tmax(0.43±0.09) and(0.38±0.14) h,t1/2(3.46±0.72) and(3.19±0.70) h,AUC0~t(23.17±7.47) and(23.17±6.64) μg·h·mL-1,AUC0~∞(25.13±7.63) and(24.97±6.94) μg·h·mL-1.The relative bioavailability of two preparations was(101.5±11.2) %.No significant differeneces between the two preparations were found in Cmax,Tmax and AUC.Conclusion: The test and reference preparations of fudosteine are bioequivalent.

Key concepts: Bioequivalence, Cmax, Pharmacokinetics, Bioavailability, Crossover study, Pharmacology, Medicine, High-performance liquid chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and bioequivalence of fudosteine granules and tablets in healthy volunteers — Research Paper | ScholarLens